News

DKSH to sell, distribute seven Biocon Pharma’s generic formulations in Singapore and Thailand

DKSH will gain an exclusive license to register and commercialize seven generic formulations from various therapeutic areas and will be sold under Biocon’s brand in Singapore and Thailand.

Read More

Jun 24, 2020

By : Team ABLE

AarogyaAI Innovations from India among seven genomic startups selected by Illumina Accelerator

AarogyaAI Innovations Pvt Ltd, a diagnostics company from India, comprehensively diagnoses drug-resistance in tuberculosis rapidly.

Read More

Jun 24, 2020

By : Team ABLE

C-CAMP, Applied Materials India assist biotech startups to increase availability of indigenous medical supplies during COVID-19

Two startups, Coeo Labs and Biomoneta, were chosen by C-CAMP’s COVID-19 Innovations Deployment Accelerator (C-CIDA).

Read More

Jun 24, 2020

By : Team ABLE

NIH investigators reveal research findings on CD47 causing broad-spectrum infectious diseases immunotherapy

Their new study in mBio describes this brake and the way pathogens such as SARS-CoV-2, the virus that causes COVID-19, turn it on.

Read More

Jun 24, 2020

By : Team ABLE

Cipla launches Cipremi for treatment for patients with severe COVID-19 disease

It is claimed to be the only US FDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalized with suspected or laboratory confirmed COVID-19 infection

Read More

Jun 23, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights